Munroe Heart and Vascular Institute
Cardiology
Dr. John A. Bittl, MD
|
|
Give Review
John A. Bittl practices Cardiology. He went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 19 awards "America's Top Doctors", "Best Doctors in Ocala", "Five Star Doctors in Ocala", "Americas Top Doctors", "Top Physician", "Top 1% Physicians", "Simon Dack Prize for Scholarship and Review", "Best Cardiac Catheterization Laboratory in Florida", "Best Physicians in America", "Best Doctors in America, Southeast Region", "Best Physicians in Boston", "Best Doctors in America, Northeast Region", "Fellow", "1983 Louis N. Katz Basic Science Research Prize for Young Investigators", "Solomon Scholars Resident Research Prize", "Outstanding Research Paper", "Harold Lamport Award for Biomedical Research", "Harold C. Urey Prize for Excellence in Chemistry" and "Fellow (FACC)". John Bittl is also a published doctor. He has 47 paper published. The most recent paper is: A proposal to reduce contrast nephropathy: Eliminate the NPO order. He accepts Medicare.
Publications
- A proposal to reduce contrast nephropathy: Eliminate the NPO order.
- Family presence during catheterization procedures.
- Deconstructing Stent Polymers.
- Bayesian methods affirm the use of percutaneous Coronary intervention to improve survival in patients with unprotected left main Coronary artery disease.
- Abciximab During Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: IntraCoronary, Intravenous, or Not at All?
- Beware of large treatment effects in small clinical trials: Lessons from trials of Coronary atheroablative devices.
- Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/Americ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Associa...
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Pra...
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Associatio...
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Pr...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Associ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on...
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Associati...
- Interventional Strategies for ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
- Bioresorbable stents: the next revolution.
- Having it both ways.
- Catheter interventions for hemodialysis fistulas and grafts.
- Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access Thrombosis.
- Venous rupture during percutaneous treatment of hemodialysis fistulas and grafts.
- Adaptive remodeling of hypoplastic hemodialysis fistulas salvaged with angioplasty.
- Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
- Damage control for renal Artery stenting.
- Physical aspects of excimer laser angioplasty for undilatable lesions.
- Predictors and impact of major hemorrhage on mortality following percutaneous Coronary intervention from the REPLACE-2 Trial.
- Accounting for ACUITY.
- Outcomes of patients with Acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluati...
- The future of an illusion.
- Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous Coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Lin...
- Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous Coronary intervention: results from a 2-part, phase II, m...
- Reducing the risk of emergency bypass surgery for failed percutaneous Coronary interventions.
- Bivalirudin vs heparin in percutaneous Coronary intervention: a pooled analysis.
- Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis.
- The truth about activated clotting time measurements.
- Use of bivalirudin during percutaneous Coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous Coronary in...
- Concomitant peripheral arterial disease and Coronary artery disease: therapeutic opportunities.
- Stroke after percutaneous Coronary interventions.
- Meta-analysis of randomized trials of percutaneous transluminal Coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty.
- Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials.
- Cutting balloon angioplasty for undilatable venous stenoses causing dialysis graft Failure.
- Relationship between heparin anticoagulation and clinical outcomes in Coronary stent intervention: observations from the ESPRIT trial.
- Heparin-coated stent and heparin-induced thrombocytopenia: true, true, and conceivably related.
- Argatroban for percutaneous Coronary interventions: hit or miss?
- Coronary flow velocity and disturbed flow predict adverse clinical outcome after Coronary angioplasty.
- Percutaneous therapy of dialysis access Failure.
Schools
Johns Hopkins University School Of Medicine
University Of California Los Angeles
Brigham Womens Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- AvMed
- Blue Card PPO
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Employer Group Open Access HMO
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Medicaid
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
- America's Top Doctors
- Best Doctors in Ocala
- Five Star Doctors in Ocala
- America’s Top Doctors
- Top Physician
- Top 1% Physicians
- Simon Dack Prize for Scholarship and Review
- Best Cardiac Catheterization Laboratory in Florida
- Best Physicians in America
- Best Doctors in America, Southeast Region
- Best Physicians in Boston
- Best Doctors in America, Northeast Region
- Fellow
- 1983 Louis N. Katz Basic Science Research Prize for Young Investigators
- Solomon Scholars Resident Research Prize
- Outstanding Research Paper
- Harold Lamport Award for Biomedical Research
- Harold C. Urey Prize for Excellence in Chemistry
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
UCLA Medical Center -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1952406183 | |
| NPPES Provider LastName | BITTL | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 344716505 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952406183 |
| Last Name Of The Provider | BITTL |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Rakesh Prashad, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Premranjan P. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard O. Han, MD |
|
Dr. Gregory O. Von Mering, MD |
|
|
Dr. Ravindra Kolaventy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohan U. Jesrani, MD |
|
Dr. James F. London, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira R. Fox, MD |
|
|
Dr. Kizhake C. Kurian, MD
This Doctor is OpenDoctor Recommended.
|